Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Imataka

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Current Issues in Molecular Biology|February 25, 2025
Prostaglandins: Biological Action, Therapeutic Aspects, and Pathophysiology of Autism Spectrum DisordersKunio Yui, George Imataka, Mariko Ichihashi
Molecular Medicine Reports|January 29, 2016
Clinical features and survival in individuals with trisomy 18: A retrospective one-center study of 44 patients who received intensive care treatmentsGeorge Imataka, Hiroshi Suzumura, Osamu Arisaka
Current Issues in Molecular Biology|November 24, 2023
Lipid Peroxidation via Regulating the Metabolism of Docosahexaenoic Acid and Arachidonic Acid in Autistic Behavioral SymptomsKunio Yui, George Imataka, Tadashi Shiohama
International Journal of Molecular Sciences|October 14, 2023
Lipid Peroxidation of the Docosahexaenoic Acid/Arachidonic Acid Ratio Relating to the Social Behaviors of Individuals with Autism Spectrum Disorder: The Relationship with FerroptosisKunio Yui, George Imataka, Tadashi Shiohama
International Journal of Molecular Sciences|September 9, 2022
Lipid-Based Molecules on Signaling Pathways in Autism Spectrum DisorderKunio Yui, George Imataka, Shigemi Yoshihara
Neuroscience Letters|November 10, 2015
Down-regulation of a signaling mediator in association with lowered plasma arachidonic acid levels in individuals with autism spectrum disordersKunio Yui, George Imataka, Yohei Kawasaki, et al.
Metabolic Brain Disease|July 10, 2020
The role of lipid peroxidation in individuals with autism spectrum disordersKunio Yui, George Imataka, Hitomi Sasaki, et al.
Journal of Clinical Medicine|September 14, 2024
Gaming Disorders: Navigating the Fine Line between Entertainment and Addiction-Gaming History, Health Risks, Social Consequences, and Pathways to PreventionGeorge Imataka, Shu Izumi, Yuji Miyamoto, et al.
Cell Biochemistry and Biophysics|July 13, 2011
Drug-indiced aseptic meningitis: development of subacute sclerosing panencephalitis following repeated intraventricular infusion therapy with interferon alpha/betaGeorge Imataka, Eiji Nakagawa, Hideo Yamanouchi, et al.
Life Sciences|January 3, 2016
Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disordersKunio Yui, George Imataka, Yohei Kawasak, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Current Issues in Molecular Biology|February 25, 2025
Prostaglandins: Biological Action, Therapeutic Aspects, and Pathophysiology of Autism Spectrum DisordersKunio Yui, George Imataka, Mariko Ichihashi
Molecular Medicine Reports|January 29, 2016
Clinical features and survival in individuals with trisomy 18: A retrospective one-center study of 44 patients who received intensive care treatmentsGeorge Imataka, Hiroshi Suzumura, Osamu Arisaka
Current Issues in Molecular Biology|November 24, 2023
Lipid Peroxidation via Regulating the Metabolism of Docosahexaenoic Acid and Arachidonic Acid in Autistic Behavioral SymptomsKunio Yui, George Imataka, Tadashi Shiohama
International Journal of Molecular Sciences|October 14, 2023
Lipid Peroxidation of the Docosahexaenoic Acid/Arachidonic Acid Ratio Relating to the Social Behaviors of Individuals with Autism Spectrum Disorder: The Relationship with FerroptosisKunio Yui, George Imataka, Tadashi Shiohama
International Journal of Molecular Sciences|September 9, 2022
Lipid-Based Molecules on Signaling Pathways in Autism Spectrum DisorderKunio Yui, George Imataka, Shigemi Yoshihara
Neuroscience Letters|November 10, 2015
Down-regulation of a signaling mediator in association with lowered plasma arachidonic acid levels in individuals with autism spectrum disordersKunio Yui, George Imataka, Yohei Kawasaki, et al.
Metabolic Brain Disease|July 10, 2020
The role of lipid peroxidation in individuals with autism spectrum disordersKunio Yui, George Imataka, Hitomi Sasaki, et al.
Journal of Clinical Medicine|September 14, 2024
Gaming Disorders: Navigating the Fine Line between Entertainment and Addiction-Gaming History, Health Risks, Social Consequences, and Pathways to PreventionGeorge Imataka, Shu Izumi, Yuji Miyamoto, et al.
Cell Biochemistry and Biophysics|July 13, 2011
Drug-indiced aseptic meningitis: development of subacute sclerosing panencephalitis following repeated intraventricular infusion therapy with interferon alpha/betaGeorge Imataka, Eiji Nakagawa, Hideo Yamanouchi, et al.
Life Sciences|January 3, 2016
Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disordersKunio Yui, George Imataka, Yohei Kawasak, et al.
Pageof 7